Mst Continus (Morphine Sulfate)

Morphine sulfate, the active ingredient in Mst Continus, is an opioid analgesic presented as an oral formulation for oral use. It is employed to manage moderate to severe acute and chronic pain in adult patients when other analgesics are insufficient.

GNH USA supplies Mst Continus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Morphine sulfate is an opioid analgesic used for pain management across several clinical contexts. - Acute pain: provides rapid relief for severe short‑term pain episodes such as postoperative or trauma‑related pain. - Chronic pain: offers sustained analgesia for long‑term conditions like osteoarthritis or neuropathic pain. - Cancer‑related pain: helps control moderate to severe pain associated with malignant disease.

Morphine sulfate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Nausea: upset stomach often accompanied by vomiting. - Drowsiness: increased sedation and reduced alertness. - Dry mouth: decreased salivation. - Sweating: excessive perspiration. - Dizziness: light‑headed sensation.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - Severe hypotension: marked drop in blood pressure. - Anaphylaxis: acute allergic reaction with rash, swelling, and airway compromise. - adrenal insufficiency: impaired cortisol production. - Withdrawal syndrome: symptoms upon abrupt discontinuation after prolonged use.

When prescribing morphine sulfate, clinicians should consider several safety measures. - Assess pain severity: confirm that opioid therapy is appropriate for the level of pain. - Monitor respiratory function: watch for signs of respiratory depression, especially after dose initiation. - Use lowest effective dose: titrate to the minimum dose that provides adequate analgesia. - Avoid in severe respiratory compromise: contraindicated in patients with uncontrolled asthma or COPD exacerbations. - Caution in renal/hepatic impairment: dose adjustments may be required. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Morphine sulfate can interact with other medications, altering its safety or efficacy.

Major Interactions (Avoid): - Benzodiazepines: combined CNS depression increases risk of respiratory failure. - MAO inhibitors: may cause severe hypertension or serotonin syndrome. - Other opioids: additive effects heighten respiratory depression. - Alcohol: enhances sedative effects and respiratory risk. - Respiratory depressants (e.g., barbiturates): potentiate breathing suppression.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., erythromycin): may increase morphine plasma levels. - CYP3A4 inducers (e.g., rifampin): may reduce analgesic effect. - Antihistamines: can augment drowsiness. - Diuretics: may exacerbate hypotension. - Anticholinergics: may worsen constipation.